Order Article Reprints

Harel ET, Drake PM, Barfield RM, Lui I, Farr-Jones S, Van’t Veer L, Gartner ZJ, Green EM, Lourenço AL, Cheng Y, et al. Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer. Antibodies. 2019; 8(4):54. https://doi.org/10.3390/antib8040054

Harel, Efrat T., Penelope M. Drake, Robyn M. Barfield, Irene Lui, Shauna Farr-Jones, Laura Van’t Veer, Zev J. Gartner, Evan M. Green, André Luiz Lourenço, Yifan Cheng, and et al. 2019. "Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer" Antibodies 8, no. 4: 54. https://doi.org/10.3390/antib8040054

Harel, E. T., Drake, P. M., Barfield, R. M., Lui, I., Farr-Jones, S., Van’t Veer, L., Gartner, Z. J., Green, E. M., Lourenço, A. L., Cheng, Y., Hann, B. C., Rabuka, D., & Craik, C. S. (2019). Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer. Antibodies, 8(4), 54. https://doi.org/10.3390/antib8040054